Infugem

Indicated For

colorectal cancer

About This Medication

# Infugem (Gemcitabine) Patient Guide: How to Get Your Medication at Low or No Cost Infugem (gemcitabine injection) is a chemotherapy drug used to treat certain cancers, and while no specific manufacturer patient assistance program (PAP) exists for it based on available data, several copay assistance and general PAP options can help reduce costs for eligible patients[1][2][9]. This guide explains potential pathways, eligibility, and steps to access affordable Infugem, drawing from copay programs, third-party services, and foundations. ## About Infugem and Why Assistance Matters **Infugem** is an injectable form of **gemcitabine**, a nucleoside metabolic inhibitor that interferes with cancer cell DNA synthesis to slow tumor growth[2]. It's FDA-approved for cancers like ovarian, breast, non-small cell lung, and pancreatic cancer, often combined with drugs like **fluorouracil** and leucovorin[2]. Administered intravenously by healthcare professionals, Infugem is typically used in hospital or clinic settings for advanced or metastatic disease. Cancer treatment costs can exceed thousands per cycle, including copays, deductibles, and infusion fees. Assistance programs bridge this gap for insured or uninsured patients facing financial hardship, potentially covering copays up to $4,800–$25,000 annually or providing free medication[1][5][6]. Early application ensures uninterrupted therapy. ## Who Qualifies for Assistance? Qualification varies by program: - **Copay programs** (e.g., via RxHope): Require commercial health insurance covering Infugem; helps with out-of-pocket costs[1]. - **General PAPs** (e.g., Bausch Health, Pfizer Oncology, Merck): Often for uninsured or government-insured (Medicare/Medicaid) patients unable to afford meds; commercial insurance may disqualify[4][6][7]. - **Third-party services** like Prescription Hope: Income-based (up to ~$50K individual/$70K household, higher for larger families); works with any insurance[9]. - **Foundations** like PAN Foundation: For breast cancer patients with copays; requires diagnosis, insurance details, and income proof[5]. Patients new to therapy or with prior authorization (PA) needs (e.g., oncologist prescription, age ≥18) may qualify[2]. ## Income Eligibility Breakdown Specific PAPs for Infugem lack defined Federal Poverty Level (FPL) thresholds, but general programs use these guidelines. Prescription Hope provides a model[9]: | Household Size | Max Annual Income (Approx.) | Notes | |---------------|-----------------------------|-------| | **Individual** | $50,000 | Up to 400-500% FPL equivalent; flexible for hardship[9] | | **Couple (2)** | $70,000 | Increases with dependents[9] | | **Family of 3** | $90,000–$100,000 | Guidelines scale up[9] | | **Family of 4** | $110,000–$200,000 | Higher for larger families; exceptions possible[7][9] | *Notes: FPL-based (e.g., 400% FPL ~$60K individual in 2026); attest financial hardship for exceptions. Commercial insurance often ineligible for free meds[6][7].* ## Insurance Requirements Most programs target specific coverage: - **Commercial insurance**: Eligible for copay help if plan covers Infugem[1][5]. - **Medicare/Medicaid**: May qualify for PAPs if out-of-pocket unaffordable; Pfizer notes Medicare Extra Help alternatives first[6]. Avoid alternative funding mandates[7]. - **Uninsured**: Prime for free meds via PAPs like Merck or Bausch[4][7]. Prior authorizations common for Infugem (e.g., oncologist attestation, combo with fluorouracil)[2]. Programs like Serve You Rx verify insurance[8]. ## Step-by-Step Application Process 1. **Confirm eligibility**: Check RxHope for copay programs or PAN for breast cancer[1][5]. Use Prescription Hope for broad access[9]. 2. **Gather documents**: Prescription, proof of income (tax return), insurance card/ID, diagnosis, provider contacts[5][8][9]. 3. **Apply online/phone**: - RxHope/PAN: Visit sites or call (PAN: 1-866-316-7263)[1][5]. - Prescription Hope: Apply online; advocates handle in 48 hours[9]. - Manufacturer PAPs: Bausch (rxassist.org), Pfizer/Merck sites[4][6][7]. 4. **Doctor involvement**: Provider submits PA, attestation[2][9]. 5. **Submit & track**: Expect 2-4 weeks initial processing[9]. ## Timeline and Delivery - **Approval**: 48 hours screening (Prescription Hope), 2-4 weeks full (with docs)[9]. PAN phone apps faster[5]. - **Delivery**: Pharmacy/specialty vendor ships to home/clinic; Serve You Rx coordinates[8]. Refills auto-managed yearly[9]. - **Reauthorization**: Annual renewal; reapply with updated income[7][9]. ## Alternatives if Denied - **Switch programs**: Try PAN waitlist, Pfizer copay ($0/treatment for injectables), or Merck hardship exception[5][6][7]. - **Generic gemcitabine**: Cheaper non-branded option; PA updates list fluorouracil combos[3]. - **Other foundations**: RxAssist database for 100+ PAPs[4]. - **State aid**: Medicaid drug lists cover if CMS-eligible[10]. - **Biosimilars**: None listed for gemcitabine[2]. ## Important Disclaimer This guide synthesizes public resources as of 2026; programs change. Not medical/financial advice—consult your oncologist, pharmacist, or advisor. Eligibility not guaranteed; apply directly. Data from RxHope, PAN, etc.[1][2][5][9]. For latest, visit program sites or call. (Word count: 942)

Program information last verified: March 30, 2026